November 2, 2026 5:17 PM
Novartis heart drug failure leaves doctors seeking evidence for genetic cholesterol target
The recent failure of a Novartis Sexperimental heart drug in a large trial raised questions among cardiologists and investors about the widely held idea that reducing levels of a genetically set cholesterol carrier called lipoprotein(a) can improve h...
